Behavioral, neurophysiological, and synaptic impairment in a transgenic neuregulin1 (NRG1-IV) murine schizophrenia model

Journal of Neuroscience

Volumn 36, Issue 17, 2016, Pages 4859-4875

  Papaleo, Francesco ^a,b   Yang, Feng ^a,c   Paterson, Clare ^d   Palumbo, Sara ^a,e   Carr, Gregory V ^a,e   Wang, Yanhong ^a,c   Floyd, Kirsten ^d   Huang, Wenwei ^f   Thomas, Craig J ^f   Chen, Jingshan ^a   Weinberger, Daniel R ^a,c,g   Law, Amanda J ^a,d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PISA   (Italy)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AKT; ErbB; IC87114; Neuregulin; PIK3CD; Schizophrenia

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; EPIDERMAL GROWTH FACTOR RECEPTOR; NEUROLEPTIC AGENT; NRG1 PROTEIN, HUMAN;

ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; COGNITION; CONTROLLED STUDY; EMBRYO; GENOTYPE; IMMUNOBLOTTING; LEARNING; MALE; MEMORY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROPHYSIOLOGY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SOCIAL INTERACTION; STARTLE REFLEX; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HIPPOCAMPUS; HUMAN; METABOLISM; PHYSIOLOGY; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUREGULIN-1; NEUROPHYSIOLOGY; PHOSPHATIDYLINOSITOL 3-KINASES; PREFRONTAL CORTEX; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-4; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84966686834     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4632-15.2016     Document Type: Article

References (98)

1. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M (2002) Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22: 3708-3719. Medline
2. Agarwal A, Zhang M, Trembak-Duff I, Unterbarnscheidt T, Radyushkin K, Dibaj P, Martins de Souza D, Boretius S, Brzózka MM, Steffens H, Berning S, Teng Z, Gummert MN, Tantra M, Guest PC, Willig KI, Frahm J, Hell SW, Bahn S, Rossner MJ, et al. (2014) Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity. Cell Reports 8: 1130-1145. CrossRef Medline
3. Agim ZS, Esendal M, Briollais L, Uyan O, Meschian M, Martinez LA, Ding Y, Basak AN, Ozcelik H (2013) Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. PloS One 8: e53042. CrossRef Medline
4. Amodio DM, Frith CD (2006) Meeting of minds: the medial frontal cortex and social cognition. Nat Rev Neurosci 7: 268-277. CrossRef Medline
5. Badner JA, Gershon ES (2002) Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7: 405-411. CrossRef Medline
6. Barker GR, Warburton EC (2011) When is the hippocampus involved in recognition memory? J Neurosci 31: 10721-10731. CrossRef Medline
7. Barker GR, Bird F, Alexander V, Warburton EC (2007) Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci 27: 2948-2957. CrossRef Medline
8. Barros CS, Calabrese B, Chamero P, Roberts AJ, Korzus E, Lloyd K, Stowers L, Mayford M, Halpain S, Müller U (2009) Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc Natl Acad Sci U S A 106: 4507-4512. CrossRef Medline
9. Beierlein M, Gibson JR, Connors BW (2000) A network of electrically coupled interneurons drives synchronized inhibition in neocortex. Nat Neurosci 3: 904-910. CrossRef Medline
10. Beierlein M, Gibson JR, Connors BW (2003) Two dynamically distinct inhibitory networks in layer 4 of the neocortex. J Neurophysiol 90: 2987-3000. CrossRef Medline
11. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, et al. (1998) Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20: 70-73. CrossRef Medline
12. Braff DL, GeyerMA (1990) Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 47: 181-188. CrossRef Medline
13. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR (2001) Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49: 171-178. CrossRef Medline
14. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR (2003) Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. AmJ Psychiatry 160: 2209-2215. CrossRef Medline
15. Chen J, Kelz MB, Zeng G, Sakai N, Steffen C, Shockett PE, Picciotto MR, Duman RS, Nestler EJ (1998) Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol 54: 495-503. Medline
16. Chen YJ, Zhang M, Yin DM, Wen L, Ting A, Wang P, Lu YS, Zhu XH, Li SJ, Wu CY, Wang XM, Lai C, Xiong WC, Mei L, Gao TM (2010) ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci U S A 107: 21818-21823. CrossRef Medline
17. Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J, Meagher D, Clair DS, Waddington JL, Gill M (2004) Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs. 97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 9: 208-213. CrossRef Medline
18. Deakin IH, Law AJ, Oliver PL, Schwab MH, Nave KA, Harrison PJ, Bannerman DM (2009) Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 20: 1523-1528. CrossRef Medline
19. Deakin IH, Nissen W, Law AJ, Lane T, Kanso R, SchwabMH, Nave KA, Lamsa KP, Paulsen O, Bannerman DM, Harrison PJ (2012) Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation. Cereb Cortex 22: 1520-1529. CrossRef Medline
20. de laFuente-Sandoval C, Reyes-Madrigal F, Mao X, León-Ortiz P, Rodríguez-Mayoral O, Solís-Vivanco R, Favila R, Graff-Guerrero A, Shungu DC (2015) Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy. Int J Neuropsychopharmacol 19: pii: pyv105. CrossRef Medline
21. Del Pino I, García-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martínez de Lagrán M, Ciceri G, Gabaldón MV, Moratal D, Dierssen M, Canals S, Marín O, Rico B (2013) Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 79: 1152-1168. CrossRef Medline
22. Elvevåg B, Goldberg TE (2000) Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14: 1-21. Medline
23. Fazzari P, Paternain AV, Valiente M, Pla R, Luján R, Lloyd K, Lerma J, Marín O, Rico B (2010) Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 464: 1376-1380. CrossRef Medline
24. Glantz LA, Lewis DA (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57: 65-73. CrossRef Medline
25. Gonzalez-Burgos G, Fish KN, Lewis DA (2011) GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast 2011: 723184. CrossRef Medline
26. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, et al. (2011) Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 168: 930-946. CrossRef Medline
27. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12: 824-828. CrossRef Medline
28. Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, LawrieSM (2006) A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 9: 1477-1478. CrossRef Medline
29. Harrison PJ, Law AJ (2006) Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 60: 132-140. CrossRef Medline
30. Hayut I, Fanselow EE, Connors BW, Golomb D (2011) LTS and FS inhibitory interneurons, short-term synaptic plasticity, and cortical circuit dynamics. PLoS Comput Biol 7: e1002248. CrossRef Medline
31. Holt DJ, Lebron-Milad K, Milad MR, Rauch SL, Pitman RK, Orr SP, Cassidy BS, Walsh JP, GoffDC (2009) Extinction memory is impaired in schizophrenia. Biol Psychiatry 65: 455-463. CrossRef Medline
32. Howes OD, Murray RM (2014) Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet 383: 1677-1687. CrossRef Medline
33. Ji Y, Yang F, Papaleo F, Wang HX, Gao WJ, Weinberger DR, Lu B (2009) Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci U S A 106: 19593-19598. CrossRef Medline
34. Kato T, Abe Y, Sotoyama H, Kakita A, Kominami R, Hirokawa S, Ozaki M, Takahashi H, Nawa H (2011) Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Mol Psychiatry 16: 307-320. CrossRef Medline
35. Kawaguchi Y (1995) Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex. J Neurosci 15: 2638-2655. Medline
36. Kawaguchi Y (1997) Selective cholinergic modulation of cortical GABAergic cell subtypes. J Neurophysiol 78: 1743-1747. Medline
37. Kéri S, Kiss I, Kelemen O (2009) Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis. Mol Psychiatry 14: 118-119. CrossRef Medline
38. Knickmeyer RC, Wang J, Zhu H, Geng X, Woolson S, Hamer RM, Konneker T, Lin W, Styner M, Gilmore JH (2014) Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex 24: 1230-1246. CrossRef Medline
39. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, ShokatKM (2006) A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125: 733-747. CrossRef Medline
40. Kumari V, Das M, Zachariah E, Ettinger U, Sharma T (2005) Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology 42: 588-594. CrossRef Medline
41. Kwon OB, Longart M, Vullhorst D, Hoffman DA, Buonanno A (2005) Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci 25: 9378-9383. CrossRef Medline
42. Law AJ (2014) Genetic mouse models of neuregulin 1: gene dosage effects, isoform-specific functions, and relevance to schizophrenia. Biol Psychiatry 76: 89-90. CrossRef Medline
43. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5ʹ SNPs associated with the disease. Proc Natl Acad Sci U S A 103: 6747-6752. CrossRef Medline
44. Law AJ, Kleinman JE, Weinberger DR, Weickert CS (2007) Diseaseassociated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 16: 129-141. Medline
45. Law AJ, Wang Y, Sei Y, O'Donnell P, Piantadosi P, Papaleo F, Straub RE, Huang W, Thomas CJ, Vakkalanka R, Besterman AD, Lipska BK, Hyde TM, Harrison PJ, Kleinman JE, Weinberger DR (2012) Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinasep110delta inhibition as a potential therapeutic strategy. Proc Natl Acad Sci U S A 109: 12165-12170. CrossRef Medline
46. Lee KH, Farrow TF, Spence SA, Woodruff PW (2004) Social cognition, brain networks and schizophrenia. Psychol Med 34: 391-400. CrossRef Medline
47. Lesuisse C, Martin LJ (2002) Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death. J Neurobiol 51: 9-23. CrossRef Medline
48. Lévesque M, Parent A (1998) Axonal arborization of corticostriatal and corticothalamic fibers arising from prelimbic cortex in the rat. Cereb Cortex 8: 602-613. CrossRef Medline
49. Li B, Woo RS, Mei L, Malinow R (2007) The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54: 583-597. CrossRef Medline
50. Luo X, He W, Hu X, Yan R (2014) Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice. Biol Psychiatry 76: 120-127. CrossRef Medline
51. Luykx JJ, Vinkers CH, Bakker SC, Visser WF, van Boxmeer L, Strengman E, van Eijk KR, Lens JA, Borgdorff P, Keijzers P, Kappen TH, van Dongen EP, Bruins P, Verhoeven NM, de Koning TJ, Kahn RS, Ophoff RA (2012) A common variant in ERBB4 regulates GABA concentrations in human cerebrospinal fluid. Neuropsychopharmacology 37: 2088-2092. CrossRef Medline
52. Maat A, van Montfort SJ, de Nijs J, Derks EM, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I; GROUP Investigators (2015) Emotion processing in schizophrenia is state and trait dependent. Schizophr Res 161: 392-398. CrossRef Medline
53. Marder SR, Roth B, Sullivan PF, Scolnick EM, Nestler EJ, Geyer MA, Welnberger DR, Karayiorgou M, Guidotti A, Gingrich J, Akbarian S, Buchanan RW, Lieberman JA, Conn PJ, Haggarty SJ, Law AJ, Campbell B, Krystal JH, Moghaddam B, Sawa A, et al. (2011) Advancing drug discovery for schizophrenia. Ann NY Acad Sci 1236: 30-43. CrossRef Medline
54. Maren S, Phan KL, Liberzon I (2013) The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat Rev Neurosci 14: 417-428. CrossRef Medline
55. Marenco S, Geramita M, van der Veen JW, Barnett AS, Kolachana B, Shen J, Weinberger DR, Law AJ (2011) Genetic association of ErbB4 and human cortical GABA levels in vivo. J Neurosci 31: 11628-11632. CrossRef Medline
56. Mei L, Nave KA (2014) Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron 83: 27-49. CrossRef Medline
57. Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, Berman KF (2005) Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 62: 379-386. CrossRef Medline
58. Moon E, Rollins B, Mesén A, Sequeira A, Myers RM, Akil H, Watson SJ, Barchas J, Jones EG, Schatzberg A, Bunney WE, DeLisi LE, Byerley W, Vawter MP (2011) Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Schizophr Res 131: 52-57. CrossRef Medline
59. Moore H, Geyer MA, Carter CS, Barch DM (2013) Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models. Neurosci Biobehav Rev 37: 2087-2091. CrossRef Medline
60. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN (2004) Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 3: 287-302. CrossRef Medline
61. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87-90. CrossRef Medline
62. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium (2015) Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 18: 199-209. CrossRef Medline
63. Nicodemus KK, Luna A, Vakkalanka R, Goldberg T, Egan M, Straub RE, Weinberger DR (2006) Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry 11: 1062-1065. CrossRef Medline
64. Nicodemus KK, Law AJ, Luna A, Vakkalanka R, Straub RE, Kleinman JE, WeinbergerDR (2009) A 5ʹ promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression. Mol Psychiatry 14: 741-743. CrossRef Medline
65. Ogren SO, GoldsteinM (1994) Phencyclidine-and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11: 167-177. CrossRef Medline
66. O'Neill MF, Shaw G (1999) Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology (Berl) 145: 237-250. CrossRef Medline
67. Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, Weinberger DR, Chen J (2008) Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 28: 8709-8723. CrossRef Medline
68. Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, Crawley JN (2011) Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learn Mem 18: 534-544. CrossRef Medline
69. Papaleo F, Yang F, Garcia S, Chen J, Lu B, Crawley JN, Weinberger DR (2012) Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry 17: 85-98. CrossRef Medline
70. Paterson C, Law AJ (2014) Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood. PLoS One 9: e104172. CrossRef Medline
71. Paterson C, Wang Y, Kleinman JE, Law AJ (2014) Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development. Am J Psychiatry 171: 979-989. CrossRef Medline
72. Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, WoolfreyKM (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14: 285-293. CrossRef Medline
73. Powell SB, Weber M, Geyer MA (2012) Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci 12: 251-318. CrossRef Medline
74. Pozo K, Goda Y (2010) Unraveling mechanisms of homeostatic synaptic plasticity. Neuron 66: 337-351. CrossRef Medline
75. Queenan BN, Lee KJ, Pak DT (2012) Wherefore art thou, homeo (stasis) ? Functional diversity in homeostatic synaptic plasticity. Neural Plast 2012: 718203. CrossRef Medline
76. Rapoport JL, Giedd JN, Gogtay N (2012) Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 17: 1228-1238. CrossRef Medline
77. Rasetti R, Sambataro F, Chen Q, Callicott JH, Mattay VS, Weinberger DR (2011) Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry 68: 1207-1217. CrossRef Medline
78. Schaefer J, Giangrande E, Weinberger DR, Dickinson D (2013) The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res 150: 42-50. CrossRef Medline
79. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511: 421-427. CrossRef Medline
80. Senkowski D, Gallinat J (2015) Dysfunctional prefrontal gamma-band oscillations reflect working memory and other cognitive deficits in schizophrenia. Biol Psychiatry 77: 1010-1019. CrossRef Medline
81. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R (2006) The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet 141B: 142-148. CrossRef Medline
82. Stefanis NC, Trikalinos TA, Avramopoulos D, Smyrnis N, Evdokimidis I, Ntzani EE, Ioannidis JP, Stefanis CN (2007) Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry 62: 784-792. CrossRef Medline
83. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71: 877-892. CrossRef Medline
84. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, Ingason A, Gulcher JR, Stefansson K, St Clair D (2003) Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 72: 83-87. CrossRef Medline
85. Tan W, Wang Y, Gold B, Chen J, Dean M, Harrison PJ, Weinberger DR, Law AJ (2007) Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 282: 24343-24351. CrossRef Medline
86. Tang TT, Yang F, Chen BS, Lu Y, Ji Y, Roche KW, Lu B (2009) Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression. Proc Natl Acad Sci U S A 106: 21395-21400. CrossRef Medline
87. Ting AK, Chen Y, Wen L, Yin DM, Shen C, Tao Y, Liu X, Xiong WC, Mei L (2011) Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci 31: 15-25. CrossRef Medline
88. Toulopoulou T, Goldberg TE, Mesa IR, Picchioni M, Rijsdijk F, Stahl D, Cherny SS, Sham P, Faraone SV, Tsuang M, Weinberger DR, Seidman LJ, Murray RM (2010) Impaired intellect and memory: a missing link between genetic risk and schizophrenia? Arch Gen Psychiatry 67: 905-913. CrossRef Medline
89. Weickert CS, Tiwari Y, Schofield PR, Mowry BJ, Fullerton JM (2012) Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. Transl Psychiatry 2: e104. CrossRef Medline
90. Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR (2000) Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 57: 907-913. CrossRef Medline
91. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660-669. CrossRef Medline
92. Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ, Yin DM, Lai C, Terry AV Jr, Vazdarjanova A, Xiong WC, Mei L (2010) Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci U S A 107: 1211-1216. CrossRef Medline
93. Winterer G, Weinberger DR (2004) Genes, dopamine and cortical signalto-noise ratio in schizophrenia. Trends Neurosci 27: 683-690. CrossRef Medline
94. Woo RS, Li XM, Tao Y, Carpenter-Hyland E, Huang YZ, Weber J, Neiswender H, Dong XP, WuJ, Gassmann M, Lai C, Xiong WC, Gao TM, Mei L (2007) Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54: 599-610. CrossRef Medline
95. Xiang Z, Huguenard JR, Prince DA (1998) GABAA receptor-mediated currents in interneurons and pyramidal cells of rat visual cortex. J Physiol 506: 715-730. CrossRef Medline
96. Yang CR, Seamans JK (1996) Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J Neurosci 16: 1922-1935. Medline
97. Yin DM, Chen YJ, Lu YS, Bean JC, Sathyamurthy A, Shen C, Liu X, Lin TW, Smith CA, Xiong WC, Mei L (2013) Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1. Neuron 78: 644-657. CrossRef Medline
98. Young JW, GeyerMA (2015) Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. J Psychopharmacol 29: 178-196. CrossRef Medline